Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Citicoline wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
3 of 5 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
4 of 4 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both Citicoline and Oxiracetam have evidence — compare verdict strength side-by-side.
250-500mg daily
Morning for daytime cognitive enhancement
Cognizin® branded citicoline
800-2400mg daily in divided doses
Morning and early afternoon, Divided into 2-3 doses, With choline source
Oxiracetam powder or capsules
1-4 weeks
4-8 weeks
1-2 weeks
1-2 weeks
1-2 weeks
1-2 weeks
If choline-deficient
Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis
Nutrients (2023) · Meta analysis
Overall, citicoline improved cognitive status, with pooled standardized mean differences ranging from 0.56 (95% CI: 0.37-0.75) to 1.57 (95% CI: 0.77-2.37) in different sensitivity analyses.
Application of Citicoline in Neurological Disorders: A Systematic Review
Nutrients (2020) · Systematic review
In an animal model of nerve damage and neuropathy, citicoline stimulated regeneration and lessened pain.
Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly
Cochrane Database of Systematic Reviews (2005) · Systematic review
Positive effects on memory
Clinical efficacy and safety of nicergoline combined with oxiracetam in the treatment of vascular cognitive impairment
Pakistan journal of pharmaceutical sciences (2020) · Rct · n=120
The combined group had the highest effective rate and the total effective rate was 93.3%.
A Meta-Analysis of Au/Polypropionic Acid Nanoparticles Loaded with Olacetam for the Treatment of Vascular Cognitive Impairment
Journal of nanoscience and nanotechnology (2020) · Meta analysis
The results of the meta-analysis showed that compared with placebo and other medications, oxiracetam significantly improved the mental status of patients, Concise Mental State Checklist score [mean difference (MD)= 5.29, P < 0.01] and Montreal Cognitive Assessment score (MD = 4.32, P < 0.01).
The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis
Psychopharmacology (2018) · Meta analysis · n=44854
The pooled standardized mean difference of the treatment effects on cognitive dysfunction was 0.439 (95% confidence interval 0.374, 0.504).
Based on meta-analysis showing SMD 0.56-1.57 for cognitive status improvement. Conservative estimates due to heterogeneity across studies and varying populations (stroke, dementia, TBI). Effect sizes modest and studies show mixed quality levels.
Based on multiple meta-analyses showing cognitive improvements in vascular dementia and stroke populations. One major RCT (n=500) showed no benefit for post-stroke cognitive impairment, limiting confidence. Effects may be population-specific and less pronounced in healthy individuals.
AI-estimated from published studies. Interpret as directional guidance.
Citicoline has a higher evidence score (6/10 vs 5/10) and wins in 2 of 3 categories.
For sharpen focus, Citicoline has a higher relevance score (88 vs 75).
No known interactions between Citicoline and Oxiracetam have been documented in our database. However, always consult a healthcare provider before combining supplements.